These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12033389)

  • 21. Cefuroxime hydrolysis kinetics and stability predictions in aqueous solution.
    Wang D; Notari RE
    J Pharm Sci; 1994 Apr; 83(4):577-81. PubMed ID: 8046618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of hydrolysis of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine in aqueous solutions.
    Muszalska I
    Farmaco; 2004 Jun; 59(6):437-42. PubMed ID: 15178305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation kinetics of gonadorelin in aqueous solution.
    Hoitink MA; Beijnen JH; Bult A; van der Houwen OA; Nijholt J; Underberg WJ
    J Pharm Sci; 1996 Oct; 85(10):1053-9. PubMed ID: 8897270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single Heteroatom Substitutions in the Efavirenz Oxazinone Ring Impact Metabolism by CYP2B6.
    Cox PM; Bumpus NN
    ChemMedChem; 2016 Dec; 11(23):2630-2637. PubMed ID: 27860311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics and mechanism of the hydrolysis of thiamethoxam.
    Karmakar R; Singh SB; Kulshrestha G
    J Environ Sci Health B; 2009 Jun; 44(5):435-41. PubMed ID: 20183047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation kinetics of phentolamine hydrochloride in solution.
    Wang DP; Tu YH; Allen LV
    J Pharm Sci; 1988 Nov; 77(11):972-6. PubMed ID: 3225760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of degradation of 4-imidazolidinone prodrug types obtained from reacting prilocaine with formaldehyde and acetaldehyde.
    Larsen SW; Sidenius M; Ankersen M; Larsen C
    Eur J Pharm Sci; 2003 Oct; 20(2):233-40. PubMed ID: 14550890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics and mechanism of the hydrolytic degradation of indinavir: intramolecular catalysis.
    Toteva MM; Zanon R; Ostovic D
    J Pharm Sci; 2008 Sep; 97(9):3810-9. PubMed ID: 18186489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the instability of chlorhexidine, part I: kinetics and mechanisms.
    Zong Z; Kirsch LE
    J Pharm Sci; 2012 Jul; 101(7):2417-27. PubMed ID: 22499414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degradation of dacarbazine in aqueous solution.
    Shetty BV; Schowen RL; Slavik M; Riley CM
    J Pharm Biomed Anal; 1992 Sep; 10(9):675-83. PubMed ID: 1286132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nefopam hydrochloride degradation kinetics in solution.
    Tu YH; Wang DP; Allen LV
    J Pharm Sci; 1990 Jan; 79(1):48-52. PubMed ID: 2313576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of ertapenem in aqueous solutions.
    Zajac M; Cielecka-Piontek J; Jelińska A
    J Pharm Biomed Anal; 2007 Jan; 43(2):445-9. PubMed ID: 16914282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acid-base catalysis of N-[(morpholine)methylene]daunorubicin.
    Krause A; Jelińska A; Cielecka-Piontek J; Klawitter M; Zalewski P; Oszczapowicz I; Wąsowska M
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1024-8. PubMed ID: 22124459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation kinetics of butylmethoxydibenzoylmethane (avobenzone) in aqueous solution.
    Mbah CJ
    Pharmazie; 2007 Oct; 62(10):747-9. PubMed ID: 18236778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation study of the investigational anticancer drug clanfenur.
    Sluiter C; Kettenes-van den Bosch JJ; Hop E; van der Houwen OA; Underberg WJ; Bult A
    Int J Pharm; 1999 Aug; 185(2):227-35. PubMed ID: 10460918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-performance liquid chromatographic (HPLC) and HPLC-mass spectrometric (MS) analysis of the degradation of the luteinizing hormone-releasing hormone (LH-RH) antagonist RS-26306 in aqueous solution.
    Strickley RG; Brandl M; Chan KW; Straub K; Gu L
    Pharm Res; 1990 May; 7(5):530-6. PubMed ID: 2195493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preformulation studies for an ultrashort-acting neuromuscular blocking agent GW280430A. I. Buffer and cosolvent effects on the solution stability.
    Zhu H; Meserve K; Floyd A
    Drug Dev Ind Pharm; 2002; 28(2):135-42. PubMed ID: 11926357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of diastereomer hydrolysis kinetics to shelf-life predictions for cefuroxime axetil.
    Nguyen NA
    Pharm Res; 1991 Jul; 8(7):893-8. PubMed ID: 1924141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of phosphoramide mustard hydrolysis in aqueous solution.
    Watson E; Dea P; Chan KK
    J Pharm Sci; 1985 Dec; 74(12):1283-92. PubMed ID: 4087195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electronic and resonance effects on the ionization of structural analogues of efavirenz.
    Rabel SR; Patel M; Sun S; Maurin MB
    AAPS PharmSci; 2001; 3(4):E28. PubMed ID: 12049491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.